Caraco recalls Digoxin tablets
Pharma Compliance Alert, April 8, 2009
Caraco Laboratories issued a recall for its Digoxin tablets because they may differ in size and therefore could have more or less of the active ingredient, according to an FDA release.
Physicians use digoxin to treat heart failure and abnormal heart rhythms. A higher than labeled dose may lead to digoxin toxicity in patients with renal failure, the FDA said. A lower than labeled dose may not be effective, potentially resulting in cardiac instability.
Caraco is recalling Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, that are not expired and are within the expiration date of September 2011.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Complete Guide to Lab Safety, 3rd Ed.
The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
-
Medication Reconciliation
Dispel persistent regulatory myths that complicate medication management and walk away with focused, integrated processes to...
-
Meeting Anesthesia and Sedation Challenges
Join expert speakers Mary Hoppa, MD and Bud Pate, REHS, as they provide sustainable, comprehensive solutions to help you...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- Q&A: Incidental disclosures and patient privacy
- Q/A: Coding for telescopic intraocular lens
- What does case-mix index mean to you?
- HIPAA 5010 deadline extended, but threat remains, says AMA
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Tip: Correctly code bilateral pain management procedures
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Documentation and coding for toxic metabolic encephalopathy
- Guidance and tact key to compliant, effective physician queries
- Searched